Partners Nathan Sheers and Peter Lindsay are proud to participate at the Food & Drug Law Institute’s Annual Conference taking place in Washington, D.C. on June 14-15.

Peter Lindsay will be speaking on “The New World of Clinical Trials” with Kimberly Gold, Chief Privacy Officer, Genentech, Inc. and moderated by Stacy Cline Amin, Partner, Morrison & Foerster, LLP.

Nathan Sheers will be speaking on “Gene Therapies: Current Legal and Regulatory Challenges” with Wilson W. Bryan, Director, office of Tissues and Advanced Therapies, CBER, FDA, Mantej (Nimi) Chhina, Senior Director, Global R&D and Regulatory Policy, BioMarin Pharmaceutical, Inc. and moderated by Kalah Auchincloss, Executive Vice President and Deputy General Counsel, Greenleaf Health, Inc.

For more information and to register, visit FDLI’s Annual Conference website here.